Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-088375
Filing Date
2021-07-01
Accepted
2021-07-01 18:29:43
Documents
1
Period of Report
2021-04-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2121189-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2121189-2_4seq1.xml 4 9670
  Complete submission text file 0001104659-21-088375.txt   11091
Mailing Address C/O TARGANTA THERAPEUTICS CORPORATION 222 THIRD STREET SUITE 2300 CAMBRIDGE MA 02142
Business Address
Eldridge George A (Reporting) CIK: 0001413006 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40544 | Film No.: 211067391

Mailing Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116
Business Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116 617-443-2400
Aerovate Therapeutics, Inc. (Issuer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations